Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Data Collective IV GP, LLC (CIK 1664974) reported $55.9M across 2 reported positions in its SEC 13F filing for 2026-03-31. Largest positions: EVLV ($27.8M, 49.63%), RXRX ($18.2M, 32.60%), ($8.0M, 14.38%), ($1.9M, 3.39%), MNMD ($0, 0.00%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | EVLV | Evolv Technologies Holdings, Inc. | $27.8M | 49.63% | 4.6M | Hold |
| 2 | RXRX | Recursion Pharmaceuticals, Inc. | $18.2M | 32.60% | 5.9M | Hold |
| 3 | Horizon Quantum Holdings Ltd | $8.0M | 14.38% | 915,198 | New | |
| 4 | Definium Therapeutics, Inc. (MindMed) | $1.9M | 3.39% | 100,350 | New | |
| 5 | MNMD | Mind Medicine (MindMed) Inc. | $0 | 0.00% | 0 | Exited |
Source: SEC Form 13F filings · as of 2026-03-31